Tvardi Therapeutics (TVRD) EPS (Basic): 2013-2016
Historic EPS (Basic) for Tvardi Therapeutics (TVRD) over the last 4 years, with Dec 2016 value amounting to -$2.10.
- Tvardi Therapeutics' EPS (Basic) rose 9.52% to -$0.38 in Q3 2017 from the same period last year, while for Sep 2017 it was -$2.29, marking a year-over-year decrease of 39.63%. This contributed to the annual value of -$2.10 for FY2016, which is 110.00% down from last year.
- According to the latest figures from FY2016, Tvardi Therapeutics' EPS (Basic) is -$2.10, which was down 110.00% from -$1 recorded in FY2015.
- Over the past 5 years, Tvardi Therapeutics' EPS (Basic) peaked at -$0.74 during FY2013, and registered a low of -$2.10 during FY2016.
- For the 3-year period, Tvardi Therapeutics' EPS (Basic) averaged around -$1.32, with its median value being -$1 (2015).
- Data for Tvardi Therapeutics' EPS (Basic) shows a maximum YoY crashed of 110.00% (in 2016) over the last 5 years.
- Yearly analysis of 4 years shows Tvardi Therapeutics' EPS (Basic) stood at -$0.74 in 2013, then decreased by 14.86% to -$0.85 in 2014, then decreased by 17.65% to -$1 in 2015, then plummeted by 110.00% to -$2.10 in 2016.